SCHEMBL2665682

SCHEMBL2665682

Cc1ccc2c(c1)C(=O)N(CC1CC1)C2=O

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.49
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP3A4 P08684 1/20 0.48
GAA P10253 1/20 0.48
HPGD P15428 1/20 0.48
CYP1B1 Q16678 2/20 0.48
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
CA12 O43570 1/20 0.47
CA4 P22748 1/20 0.45
POLB P06746 1/20 0.44
ACHE P22303 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL959122 0.81 ALDH1A1 (0.50) CHRM2ALDH1A1KDM4EHPGDCA1
SCHEMBL2663601 0.80 CYP1B1 (0.48) ALDH1A1KDM4ECYP3A4GAAHPGD
SCHEMBL4093992 0.80 ALDH1A1 (0.63) ALDH1A1GAACYP1B1ACHECASP1
SCHEMBL4484872 0.80 CYP1B1 (0.48) ALDH1A1KDM4EHPGDCYP1B1ACHE
SCHEMBL13903462 0.78 CHRM2 (0.57) CHRM2CA1CA2CA9CA12
SCHEMBL1581709 0.78 CYP1B1 (0.59) ALDH1A1KDM4ECYP3A4GAAHPGD
SCHEMBL18688563 0.78 ALDH1A1 (0.72) ALDH1A1KDM4EGAAHPGDPOLB
SCHEMBL10054041 0.77 POLB (0.59) CHRM2ALDH1A1GAACYP1B1CA1
SCHEMBL6840053 0.76 HTR2A (0.56) ALDH1A1KDM4EHPGD
SCHEMBL10491309 0.76 POLB (0.63) ALDH1A1GAAHPGDCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed
WO-2002040445-A1 GLUCAGON ANTAGONISTS/INVERSE AGONISTS NOVO NORDISK A/S (DK) 2002-05-23 WO disclosed